CClinicalTrials.gg
Not yet recruitingNCT07658664GRIMSELUpdated Jun 22, 2026

Digitally Assisted Rehabilitation at Home for Older Adults After Hip Surgery (GRIMSEL)

An interventional study of Digitally supported multimodal rehabilitation program and routine care in Hip Surgery, Rehabilitation Program and Geriatrics Rehabilitation, sponsored by Insel Gruppe AG, University Hospital Bern. Not yet recruiting. Open to participants aged 55 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-06-22.

Sponsored by Insel Gruppe AG, University Hospital Bern · Not applicable, Interventional, and Health services research

Phase
Not applicable
Study type
Interventional
Enrollment
66
Allocation
Randomized
Ages
55 Years to 80 Years
Sex
All
01

Study summary

The goal of this clinical trial is to learn if a 12-week digitally supported, multimodal home rehabilitation program using the medical application Akina is as effective compared to routine care regarding functional independence in older adults undergoing hip surgery.

How is this multimodal home rehabilitation program received by patients? Is this multimodal home program at least as effective in terms of functional indpendence, muscle status, mobility and quality of life compared to routine care?

Researchers will compare the multimodal rehabilitation program using the application Akina to routine care to see if the program works to treat patients after hip surgery.

Participants will:

Undergo the rehab program at home or receive routine care (outpatient physiotherapy) for 12 weeks Visit the clinic after 6 and 12 weeks

02

Conditions studied

  • Hip Surgery
  • Rehabilitation Program
  • Geriatrics Rehabilitation
  • Digital Health Intervention

Keywords

  • functional independence
  • home-based rehabilitation
  • self-management
  • orthogeriatrics
03

In context

Lead sponsor

Insel Gruppe AG, University Hospital Bern is the lead sponsor of 724 studies on the registry; 177 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
55 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Community-dwelling adults aged 55 to 80 years
  • Hospitalized for hip surgery with unrestricted weight bearing at University Hospital Bern

Exclusion criteria

Exclusion Criteria:

  • Discharge to inpatient rehabilitation
  • inability to comply with a rehabilitation program (e.g. comorbidity that prevents 30min light workout, major cognitive impairment)
  • end-of life situation
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
66 participants (estimated)

Study arms

  • Active comparator
    Routine care

    Routine care (outpatient physiotherapy)

    Other: routine care

  • Experimental
    Digitally supported multimodal home rehabilitation

    Other: Digitally supported multimodal rehabilitation program

Interventions

  • OtherDigitally supported multimodal rehabilitation program

    Multimodal personalized rehabilitation program including the medical application Akina and self-managed care based on a geriatric assessment

  • Otherroutine care

    routine care

06

What researchers measure

Primary outcomes

  1. FIM motor subscale

    Change of the Functional independence measure (FIM) motor subscale from baseline to follow-up (12 weeks after surgery) between intervention and control group. The FIM motor subscale is a 13-item assessment tool ranging from a minimum of 13 points (dependence) to a maximum of 91 points (independence)

    Time frame: from baseline (day 1 post-surgery) to follow-up (12 weeks after surgery)

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 22, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07658664
Lead sponsor
Insel Gruppe AG, University Hospital Bern
Responsible party
Sponsor
First posted
Jun 22, 2026
Start date
Aug 2026 (estimated)
Primary completion
Sep 2027 (estimated)
Completion
Aug 2028 (estimated)
Last update
Jun 22, 2026

Study contacts

Anna K. Eggimann, PD Dr. med.
Contact
anna.eggimann@insel.ch
+41 31 632 21 11

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion